These grants support investigator-initiated projects in basic biomedical research. Projects funded under these grants could lead to new or improved technologies, including instruments, devices and methodologies algorithm or software that will have application to a broad range of biomedical research.
Investigator-Initiated Research Grants (R01) support research that may involve a concept, design, fabrication and/or test of technologies, with the overall objective of leading to more powerful and useful tools for biomedical research. The application is expected to include preliminary data that supports the proposed project.
Scientific Conference Grants (R13/U13) support meetings sponsored and directed by the grant recipient. Such meetings must be relevant to the goals of the biomedical technology program.
Academic Research Enhancement Awards (AREA) (R15) are an NIH effort to stimulate research in educational institutions that provide baccalaureate training for a significant number of the nation's research scientists but that have not been major recipients of NIH support. The biomedical technology program supports resource-related research projects proposed by faculty members of eligible institutions. This award enables qualified scientists to receive support for up to 3 years for small-scale research projects.
Technology Development Exploratory Research Grants (R21) support research on novel concepts that have not yet been tested for feasibility. These grants reward high-risk or novel approaches with potential for significant impact. This NIGMS R21 mechanism must not have preliminary data and cannot be renewed.
For more information about biomedical technology program support for investigator-initiated research grants, contact:
Judith Greenberg, Ph.D. Acting DirectorDivision of Biophysics, Biomedical Technology, and Computational Biosciences National Institute of General Medical Sciences National Institutes of Health 45 Center Drive MSC 6200 Bethesda, MD 20892-6200
This page last reviewed on
2/21/2020 10:57 AM
Connect With Us: